Skip to content
CANCER BUZZ cover art

All episodes

CANCER BUZZ, 300 episodes. Page 3 of 3.

#
Title
201

Alleviating the Psycho-social Burden of MPNs

202

Myelofibrosis: Advances in Treatment and Therapy

203

ACCC's 2023 Advocacy Agenda and Priorities

204

Symptoms Scoring and Risk Stratification for Myelofibrosis

205

Utilizing Subcutaneous and IV Treatment for Improved Outcomes with Multiple Myeloma Patients

206

A Better Patient Experience in the Management of Incidental Lung Nodules

207

In the Know: New Treatment Guidelines for Myeloproliferative Neoplasms

208

Mitigating the Financial Burden of Cancer Diagnostics

209

Getting the Green Light for Precision Medicine Stewards

210

The Impact of Integrated Care on Myeloproliferative Neoplasms (MPNs)

211

Treatment Options for Patients with Multiple Myeloma Who Are Ineligible for Transplant

212

Best Practices in Caring for Patients with CLL in a Post-COVID Era

213

Addressing Regional Challenges to Equitable Care for Patients with CLL

214

Robots, Biologics, and Advocates: Lessons from the Pharmacy

215

Precision Medicine: Stories from the CRISPR Revolution

216

The Urgency of MPN Treatment – Why Timing Matters

217

The Role of Population Health Navigators

218

Prioritizing a Multidisciplinary Team Approach in the Care of Patients with Small Cell Lung Cancer

219

Nurses' Role in Oral Oncolytics for CLL

220

A Conversation with ACCC Board Member Dr. Nadine Barrett

221

Improving Clinical Efficiency: EHR & MPN10 Integration

222

Multi-Cancer Early Detection: Legislative Landscape

223

Optimizing SCLC Patient Outcomes Through Multidisciplinary Care Coordination

224

Advanced Skin Cancer Care for Rural Populations

225

The Importance of Having Difficult Conversations with Patients

226

Engaging Patients with Small Cell Lung Cancer in Clinical Trials

227

Social Media as a Platform to Deliver Patient Education

228

Navigating Cancer Diagnostics – A Closer Look at the Role of the Precision Medicine Steward

229

Technology That is Transforming Cancer Care

230

Is It time to Cancel the Term "A Cure for Cancer"

231

Overcoming Health Disparities through Remote Patient Monitoring

232

Financial Barriers to Oral Cancer Therapies

233

LIVE from NOC: Leveraging Data to Tackle Workforce Shortages

234

LIVE from NOC: Building Sustainable Coalitions in Your Community

235

LIVE from NOC: A Support Program to Improve Staff Well-Being

236

LIVE from NOC: Advocates Weigh-In on Financial Advocacy Guidelines Update

237

LIVE from NOC: Financial Advocacy Guidelines

238

Successful Integration of Oral Oncolytics

239

Patient Adherence to Oral Targeted Therapies

240

CAR T-cell Therapy: Remote Patient Monitoring

241

Addressing Challenges in Managing Patients Receiving Oral Therapies for HR+, HER2- Breast Cancer

242

Interventional Screening Tools for Malnutrition

243

Sexual Health: All of Me

244

Malnutrition: Screen or Assess?

245

Anti-Cancer Therapy Privileging for APPs

246

Expediting Cancer Treatment Through a Rapid Access APP-Led Diagnostic Clinic

247

Deploying Technology Across an Interdisciplinary Team to Improve Oral Oncolytic Compliance

248

Chemotherapy Care Companion: A Remote Patient Monitoring Program

249

Malnutrition in Cancer Care

250

A Model for Embedding Primary Care in Oncology

251

Oral Cancer Therapy: Adverse Events

252

Addressing Social Determinants of Health through a Medical-Legal Partnership

253

Digital Literacy in Older Adults with Cancer

254

Cannabis and Cancer: Developing a Patient Clinic

255

Advocating for Financial Health

256

Pharmacy Benefit Managers: How Advocacy Led to Action

257

Increasing Clinical Trial Access for Blood Cancers

258

Expanding the Role of Advanced Practitioners to Address the Care Gap

259

Liquid Biopsy: Cancer Detection & Future Synergies

260

Two ACCC Presidential Themes Converge at One Annual Meeting

261

The Promise of MRD Testing in Multiple Myeloma & CLL

262

State Advocacy Matters

263

Jack's Caregiver Coalition

264

Virtual Integrative Services

265

AMCCBS LIVE: Precision Medicine Reimbursement

266

AMCCBS LIVE: Care Measurement

267

AMCCBS LIVE: Cancer Moonshot

268

AMCCBS LIVE: Industry Reconfiguration Trends

269

Digital Patient Assistance Guide

270

Improving Pathology Reports

271

Developments in TIL Cell Therapy

272

The Business Case for Hiring Oncology Social Workers

273

Biomarker Testing Advocacy

274

Genetic Counseling Advocacy

275

Leading with Gratitude

276

QI in Advanced NSCLC

277

A New Deal for Cancer

278

Precision Medicine Disparities

279

Shared Decision-Making in Acute Myeloid Leukemia

280

Genetic Testing & Telehealth

281

Cancer Care's Road to Recovery from the Global Pandemic

282

Supportive Care in Radiation Oncology

283

Financial Advocacy Playbook

284

Coping with Pandemic Grief

285

CLL, COVID-19, & Why Patient Registries Matter

286

Integrating Advanced Practitioners into Research

287

Implementing a Transportation Hub

288

Chronic Lymphocytic Leukemia: Navigating Uncertainty

289

A Summer of Disconnect for Cancer Professionals

290

Advanced Practitioners' Role in Research

291

Oncology Billing & Coding Fundamentals

292

CLL Patient Education in Transitional Times

293

The IT Professional as a Multidisciplinary Team Member

294

Advancing Clinical Trial Equity

295

Myeloma Care Strategies & COVID-19

296

Real-World Lessons from COVID-19

297

Collaboration and Innovation in the Time of COVID-19

298

Impact of COVID-19 on Revenue Optimization

299

COVID-19 Challenges: Managing Patients with CLL

300

What Comes Next for Telehealth?